Magdalena B Flak
Affiliation: Queen Mary
- p21 Promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarkerMagdalena B Flak
Centre for Molecular Oncology and Imaging, Institute of Cancer, Barts and the London School of Medicine, Queen Mary University of London, London EC1 M 6BQ, UK
Mol Cancer 9:175. 2010..These results highlight that host cell factors beyond simple infectivity can influence the efficacy of oncolytic adenoviruses. p21 expression may be an important biomarker of response in clinical trials...
- Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cellsClaire M Connell
Centre for Molecular Oncology and Imaging, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
J Clin Invest 121:1283-97. 2011....